Botulinum Toxin for the Treatment of Migraine and Other Primary Headache Disorders

The document discussed the use of Botulinum toxin (BoNTA) as a new treatment option for chronic pain syndromes such as migraines and tension-type headaches. Traditional headache medications often caused side effects like dizziness, fatigue, weight gain, hair loss, and loss of libido, which BoNTA did not cause. Additionally, BoNTA had a long duration of action, eliminating the need for daily medication, contributing to its high safety profile and patient acceptability. However, there were differing opinions on dosages, injection areas, and patient selection, and comparative studies with standard treatments were still needed. Therefore, BoNTA was recommended only after standard treatments were exhausted and should be evaluated in specialist centers.